|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of pulmonary diseases and disorders; Pharmaceutical... |
|
|
Invention
|
Modified aspartyl-trna synthetases. Provided are modified aspartyl-tRNA synthetase (AspRS or DARS... |
|
2024
|
Invention
|
Compositions and methods comprising anti-nrp2 antibodies.
Provided are antibodies and antigen-bi... |
|
2023
|
Invention
|
Compositions comprising anti-nrp2 antibodies. Provided are affinity matured and humanized antibod... |
|
|
Invention
|
Compositions and methods comprising anti-nrp2 antibodies.
Provided are antibodies, and antigen-b... |
|
|
Invention
|
Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies, and antigen-bi... |
|
|
Invention
|
Compositions and methods comprising anti-nrp2b antibodies.
Provided are antibodies and antigen-b... |
|
|
Invention
|
Compositions and methods comprising anti-nrp2b antibodies. Provided are antibodies and antigen-bi... |
|
2022
|
Invention
|
Compositions and methods comprising anti-nrp2a antibodies.
Provided are antibodies and antigen-b... |
|
|
Invention
|
Compositions and methods comprising anti-nrp2a antibodies. Provided are antibodies and antigen-bi... |
|
|
Invention
|
Compositions and methods comprising anti-nrp2 antibodies. Provided are antibodies and antigen-bin... |
|
|
Invention
|
Compositions and methods for treating nrp2-associated diseases.
Provided are therapies, includin... |
|
2021
|
Invention
|
Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical... |
|
|
Invention
|
Histidyl-trna synthetase-fc conjugates.
The present invention provides histidyl-tRNA synthetase ... |
|
2020
|
Invention
|
Therapeutic compositions comprising anti-nrp2 antibodies. Provided are affinity matured and human... |
|
|
Invention
|
Compositions and methods comprising anti-nrp2 antibodies. Provided are affinity matured and human... |
|
|
Invention
|
Histidyl-trna synthetase-fc conjugates. The present invention provides histidyl-tRNA synthetase a... |
|
2019
|
Invention
|
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fra... |
|
|
Invention
|
Compositions and methods for treating nrp2-associated diseases. Provided are therapies, including... |
|
2018
|
Invention
|
Compositions and methods for treating lung inflammation. Provided are therapies, including combin... |
|
2017
|
Invention
|
Anti-hrs antibodies and combinaton therapies for treating cancers.
Provided are antibodies that ... |
|
|
Invention
|
Anti-hrs antibodies and combination therapies for treating cancers. Provided are antibodies that ... |
|
|
Invention
|
Compositions and methods comprising glycyl-trna synthetases having non-canonical biological activ... |
|
2016
|
Invention
|
Aminoacyl trna synthetases for modulating inflammation. Inflammatory and other cellular response-... |
|
|
Invention
|
Thrombopoietic activity of tyrosyl-trna synthetase polypeptides.
Thrombopoietic compositions are... |
|
2013
|
P/S
|
Pharmaceutical preparations for the treatment of vascular disorders, inflammatory disorders, name... |
|
2007
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
pharmaceutical research and development |
